Pharma and Biotech Daily: AbbVie Acquires Gilgamesh, IPO Stalemate Ends, Oral Obesity Therapies Disappoint

by Pharma and BioTech Daily

  • 2025-08-26 05:00:00Release date
  • 01:16Length